OLT1177

dapansutrile · Olatec Therapeutics LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OLT1177, covering 2012-09-06 to 2012-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects [Phase 1]